TOWNSEND RICHARD NOLAN (Chief Executive Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2026ACC: 0001995218-26-000002
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+808.33K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
808.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+161.66K
Price / share
—
Trade value
—
% of position
67.1%
2/4/2026
240.99K→402.66K
Total
Net shares
+161.66K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | A · Award | +161.66K | — | — | 67.1% | 240.99K | 402.66K |
| Total | +161.66K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
260K shares
Shares
+646.66K
Strike price
7.27
Held after
646.66K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock260K shares | 2/4/2026 | A · Award | +646.66K | 7.27 | — | 646.66K |